Cancer And Accelerated Approval: FDA To Crack Down On Single-Arm Trials, Refractory Disease Focus

 
• By Sarah Karlin-Smith
man doing one arm push up with child on back
FDA wants sponsors to curtail use of single-arm studies in oncology. • Source: Shutterstock

More from Approval Standards

More from Pathways & Standards